Drug Shortage Report for PMS-ERLOTINIB

Last updated on 2018-05-05 History
Report ID 6123
Drug Identification Number 02454386
Brand name PMS-ERLOTINIB
Common or Proper name ERLOTINIB
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) ERLOTINIB
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2017-07-14
Actual start date 2017-07-14
Estimated end date Unknown
Actual end date 2018-05-04
Shortage status Resolved
Updated date 2018-05-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2018-05-05 English Compare
v12 2018-05-04 French Compare
v11 2018-05-04 English Compare
v10 2017-10-11 French Compare
v9 2017-10-11 English Compare
v8 2017-07-15 English Compare
v7 2017-06-23 French Compare
v6 2017-06-23 English Compare
v5 2017-06-16 French Compare
v4 2017-06-16 English Compare
v3 2017-04-29 English Compare
v2 2017-04-07 French Compare
v1 2017-04-07 English Compare

Showing 1 to 13 of 13